Sarepta Therapeutics
Utility Patents

Last updated:

List of all Sarepta Therapeutics patents 8 in total

Status Patent
Grant
Utility: Exon skipping oligomer conjugates for muscular dystrophy External link
Filling date: 6 Sep 2025 Issue date: 26 Jul 2022
Grant
Utility: Processes for preparing oligomers External link
Filling date: 6 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Exon skipping oligomer conjugates for muscular dystrophy External link
Filling date: 6 Sep 2025 Issue date: 12 Jul 2022
Grant
Utility: Exon skipping oligomer conjugates for muscular dystrophy External link
Filling date: 6 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Antisense-induced exon2 inclusion in acid alpha-glucosidase External link
Filling date: 6 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: Functionally-modified oligonucleotides and subunits thereof External link
Filling date: 6 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Oligonucleotide analogues targeting human LMNA External link
Filling date: 6 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: DsRNA molecules comprising oligonucleotide analogs having modified intersubunit linkages and/or terminal groups External link
Filling date: 6 Sep 2025 Issue date: 27 Jul 2021

Showing 1 to 8 of 8 patents.